Yung Zip Chemical Ind. Co., Ltd. (TPEX:4102)
Taiwan · Delayed Price · Currency is TWD 18.90
0.00 (0.00%)
At close: Apr 24, 2026
Yung Zip Chemical Ind. Revenue
In the year 2025, Yung Zip Chemical Ind. had annual revenue of 474.22M TWD, down -18.76%. Yung Zip Chemical Ind. had revenue of 113.85M in the quarter ending December 31, 2025, with 11.32% growth.
Revenue
474.22M
Revenue Growth
-18.76%
P/S Ratio
1.69
Revenue / Employee
2.52M
Employees
188
Market Cap
800.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 474.22M | -109.47M | -18.76% |
| Dec 31, 2024 | 583.70M | 24.54M | 4.39% |
| Dec 31, 2023 | 559.15M | -8.18M | -1.44% |
| Dec 31, 2022 | 567.33M | 89.74M | 18.79% |
| Dec 31, 2021 | 477.60M | 14.38M | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lotus Pharmaceutical | 20.51B |
| PharmaEssentia | 15.63B |
| Kim Forest Enterprise | 549.14M |
| Radiant Innovation | 387.58M |
| Sofiva Genomics | 385.71M |
| BioLASCO Taiwan | 262.66M |
| NatureWise Biotech & Medicals | 180.29M |
| Caliway Biopharmaceuticals | 38.04M |